Evidence map›Paper›PMID 36579509›Full record

ArticleJournal of personalized medicine2022

The Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission): Design and Implementation.

Alison D Archibald, Belinda J McClaren, Jade Caruana, Erin Tutty, Emily A King, Jane L Halliday, Stephanie Best, Anaita Kanga-Parabia, Bruce H Bennetts, Corrina C Cliffe and 36 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
21.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors at 18 institutions in 2 countries.

Alison D ArchibaldVictorian Clinical Genetics Services, Parkville, VIC 3052, Australia.
Belinda J McClarenMurdoch Children's Research Institute, Parkville, VIC 3052, Australia.
Jade CaruanaMurdoch Children's Research Institute, Parkville, VIC 3052, Australia.ORCID 0000-0003-0335-6224
Erin TuttyMurdoch Children's Research Institute, Parkville, VIC 3052, Australia.
Emily A KingMurdoch Children's Research Institute, Parkville, VIC 3052, Australia.
Jane L HallidayMurdoch Children's Research Institute, Parkville, VIC 3052, Australia.ORCID 0000-0001-6206-3857
Stephanie BestAustralian Genomics, Parkville, VIC 3052, Australia.
Anaita Kanga-ParabiaVictorian Clinical Genetics Services, Parkville, VIC 3052, Australia.
Bruce H BennettsSydney Genome Diagnostics, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
Corrina C CliffeNSW Health Pathology Randwick Genomics Laboratory, Randwick, NSW 2031, Australia.
Evanthia O MadelliMurdoch Children's Research Institute, Parkville, VIC 3052, Australia.ORCID 0000-0002-2128-0828
Gladys HoSydney Genome Diagnostics, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
Jan LiebeltSouth Australian Clinical Genetics Service, North Adelaide, SA 5006, Australia.
Janet C LongAustralian Institute of Health Innovation, Macquarie University, North Ryde, NSW 2109, Australia.
Jeffrey BraithwaiteAustralian Genomics, Parkville, VIC 3052, Australia.
Jillian KennedyGenetic Services of Western Australia, Subiaco, WA 6008, Australia.
John MassieMurdoch Children's Research Institute, Parkville, VIC 3052, Australia.ORCID 0000-0003-1008-0967
Jon D EmeryDepartment of General Practice and Centre for Cancer Research, University of Melbourne, Melbourne, VIC 3000, Australia.
Julie McGaughranGenetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD 4006, Australia.
Justine E MarumVictorian Clinical Genetics Services, Parkville, VIC 3052, Australia.
Kirsten BoggsAustralian Genomics, Parkville, VIC 3052, Australia.
Kristine Barlow-StewartNorthern Clinical School, Faculty of Medicine and Health, University of Sydney, St Leonards, NSW 2065, Australia.
Leslie BurnettNorthern Clinical School, Faculty of Medicine and Health, University of Sydney, St Leonards, NSW 2065, Australia.ORCID 0000-0001-7282-9596
Lisa DiveGraduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia.ORCID 0000-0001-6655-5138
Lucinda FreemanGraduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Mark R DavisDepartment of Diagnostic Genomics, PathWest Laboratory Medicine, Nedlands, WA 6009, Australia.
Martin J DownesMenzies Health Institute Queensland, Griffith University, Gold Coast, QLD 4222, Australia.ORCID 0000-0003-3617-5307
Mathew WallisTasmanian Clinical Genetics Service, Tasmanian Health Service, Hobart, TAS 7000, Australia.
Monica M FerrieVictorian Clinical Genetics Services, Parkville, VIC 3052, Australia.
Nicholas PachterGenetic Services of Western Australia, Subiaco, WA 6008, Australia.
Paul A ScuffhamMenzies Health Institute Queensland, Griffith University, Gold Coast, QLD 4222, Australia.ORCID 0000-0001-5931-642X
Rachael CasellaIndependent Researcher.
Richard J N AllcockDepartment of Diagnostic Genomics, PathWest Laboratory Medicine, Nedlands, WA 6009, Australia.
Royston OngHarry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
Samantha EdwardsHarry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.ORCID 0000-0002-1219-5613
Sarah RighettiCentre for Clinical Genetics, Sydney Children's Hospital, Randwick, NSW 2031, Australia.ORCID 0000-0002-7430-3288
Sebastian LunkeVictorian Clinical Genetics Services, Parkville, VIC 3052, Australia.ORCID 0000-0002-7168-0723
Sharon LewisMurdoch Children's Research Institute, Parkville, VIC 3052, Australia.
Susan P WalkerMercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC 3084, Australia.
Tiffany F BoughtwoodMurdoch Children's Research Institute, Parkville, VIC 3052, Australia.ORCID 0000-0002-9634-3731
Tristan HardyMonash IVF Group, Richmond, VIC 3121, Australia.
Ainsley J NewsonAustralian Genomics, Parkville, VIC 3052, Australia.ORCID 0000-0002-3460-772X
Edwin P KirkNSW Health Pathology Randwick Genomics Laboratory, Randwick, NSW 2031, Australia.
Nigel G LaingDepartment of Diagnostic Genomics, PathWest Laboratory Medicine, Nedlands, WA 6009, Australia.ORCID 0000-0001-5111-3732
Martin B DelatyckiVictorian Clinical Genetics Services, Parkville, VIC 3052, Australia.
The Mackenzie's Mission Study Team
The University of Melbourne · AUThe University of Sydney · AUMurdoch Children's Research Institute · AUThe University of Western Australia · AUGriffith University · AUHarry Perkins Institute of Medical Research · AUSouth Australia Pathology · AUUniversity of Technology Sydney · AUUNSW Sydney · AUBreast Cancer Network Australia · AUChildren's Hospital at Westmead · AUInternational Society for Quality in Health Care · IEMacquarie University · AURoyal Children's Hospital · AUServices Australia · AUThe University of Queensland · AUUniversity of Tasmania · AUVictorian Clinical Genetics Services · AU

Funding

Australian Government GHFM73390
6 · The paper itself

Abstract

Reproductive genetic carrier screening (RGCS) provides people with information about their chance of having children with autosomal recessive or X-linked genetic conditions, enabling informed reproductive decision-making. RGCS is recommended to be offered to all couples during preconception or in early pregnancy. However, cost and a lack of awareness may prevent access. To address this, the Australian Government funded Mackenzie’s Mission—the Australian Reproductive Genetic Carrier Screening Project. Mackenzie’s Mission aims to assess the acceptability and feasibility of an easily accessible RGCS program, provided free of charge to the participant. In study Phase 1, implementation needs were mapped, and key study elements were developed. In Phase 2, RGCS is being offered by healthcare providers educated by the study team. Reproductive couples who provide consent are screened for over 1200 genes associated with >750 serious, childhood-onset genetic conditions. Those with an increased chance result are provided comprehensive genetic counseling support. Reproductive couples, recruiting healthcare providers, and study team members are also invited to complete surveys and/or interviews. In Phase 3, a mixed-methods analysis will be undertaken to assess the program outcomes, psychosocial implications and implementation considerations alongside an ongoing bioethical analysis and a health economic evaluation. Findings will inform the implementation of an ethically robust RGCS program.

Indexed as

bioethicshealth economicsimplementation sciencepsychosocial outcomesreproductive genetic carrier screening

Identifiers

PMID36579509
PMCPMC9698511
OpenAlexW4307617206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.